Hwang‐Phill Kim

1.9k total citations
42 papers, 1.5k citations indexed

About

Hwang‐Phill Kim is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hwang‐Phill Kim has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hwang‐Phill Kim's work include Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (9 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). Hwang‐Phill Kim is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (9 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). Hwang‐Phill Kim collaborates with scholars based in South Korea, Ethiopia and Puerto Rico. Hwang‐Phill Kim's co-authors include Sae‐Won Han, Tae‐You Kim, Seock‐Ah Im, Yung‐Jue Bang, Do‐Youn Oh, Young‐Kwang Yoon, Sang‐Hyun Song, Sang Eun Lee, Hyung-Seok Hur and Ik‐Soon Jang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hwang‐Phill Kim

39 papers receiving 1.4k citations

Peers

Countries citing papers authored by Hwang‐Phill Kim

Since Specialization

Citations

This map shows the geographic impact of Hwang‐Phill Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hwang‐Phill Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hwang‐Phill Kim more than expected).

Fields of papers citing papers by Hwang‐Phill Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hwang‐Phill Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hwang‐Phill Kim. The network helps show where Hwang‐Phill Kim may publish in the future.

Co-authorship network of co-authors of Hwang‐Phill Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Hwang‐Phill Kim. A scholar is included among the top collaborators of Hwang‐Phill Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hwang‐Phill Kim. Hwang‐Phill Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non–Small Cell Lung Cancer 2024 ·Cancer Research and Treatment ·(unknown), Jeonghwan Youk, Yoojoo Lim, (unknown), (unknown), Hwang‐Phill Kim, Duhee Bang, Bhumsuk Keam, (unknown), Miso Kim, Dong-Wan Kim, Tae‐You Kim	5
2	Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target 2024 ·BMC Veterinary Research ·Seo‐Young Park, Yeong‐Bin Baek, Chanho Lee, Hyunjin Kim, Hwang‐Phill Kim, Young-Jun Jeon, (unknown), Subin Jung, Hyo-Jin Kim, (unknown), Sang‐Ik Park, Chang‐Min Lee, Sung-Hak Kim	0
3	Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses 2024 ·Translational Lung Cancer Research ·Sehhoon Park, (unknown), Naeun Lee, Se‐Hoon Lee, Hwang‐Phill Kim, Su Yeon Kim, Tae‐You Kim, Hye Min Kim, Hyun Ae Jung, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park	5
4	Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer 2023 ·British Journal of Cancer ·Seung‐Bum Ryoo, (unknown), Yoojoo Lim, (unknown), (unknown), (unknown), (unknown), Su Yeon Kim, Hwang‐Phill Kim, Duhee Bang, Sung‐Bum Kang, Chang Sik Yu, Seong Taek Oh, Ji Won Park, Seung‐Yong Jeong, Young-Joon Kim, Kyu Joo Park, Sae‐Won Han, Tae‐You Kim	15
5	EBS-seq: enrichment-based method for accurate analysis of 5-hydroxymethylcytosine at single-base resolution 2023 ·Clinical Epigenetics ·(unknown), (unknown), Hwang‐Phill Kim, Tae‐You Kim, Duhee Bang	2
6	EMT-mediated regulation of CXCL1/5 for resistance to anti-EGFR therapy in colorectal cancer 2022 ·Oncogene ·Ye‐Lim Park, Hwang‐Phill Kim, Chan‐Young Ock, (unknown), Jun Kang, Yoojoo Lim, Sang‐Hyun Song, Sae‐Won Han, (unknown)	17
7	Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment 2022 ·British Journal of Cancer ·Sheehyun Kim, Yoojoo Lim, (unknown), Hwang‐Phill Kim, (unknown), Su Yeon Kim, (unknown), Duhee Bang, Seung‐Yong Jeong, Kyu Joo Park, Sae‐Won Han, Tae‐You Kim	25
8	Asymmetrical barcode adapter-assisted recovery of duplicate reads and error correction strategy to detect rare mutations in circulating tumor DNA 2017 ·Scientific Reports ·(unknown), Byungjin Hwang, Ha Young Kim, Hoon Jang, Hwang‐Phill Kim, Sae‐Won Han, Tae‐You Kim, Ji Hyun Lee, Duhee Bang	4
9	Dynamic cohesin‐mediated chromatin architecture controls epithelial–mesenchymal plasticity in cancer 2016 ·EMBO Reports ·Jiyeon Yun, Sang‐Hyun Song, Hwang‐Phill Kim, Sae‐Won Han, Eugene C. Yi, Tae‐You Kim	26
10	Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability 2015 ·Nucleic Acids Research ·Jiyeon Yun, Sang‐Hyun Song, (unknown), Jinah Park, Hwang‐Phill Kim, Sae‐Won Han, Tae‐You Kim	19
11	RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib 2013 ·Molecular Cancer Therapeutics ·Ahrum Min, Seock‐Ah Im, Young‐Kwang Yoon, Sang‐Hyun Song, (unknown), Hyung-Seok Hur, Hwang‐Phill Kim, Kyung-Hun Lee, Sae‐Won Han, Do‐Youn Oh, Tae‐You Kim, Mark J. O’Connor, Woo Ho Kim, Yung‐Jue Bang	109
12	OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells 2013 ·Cancer Letters ·Mi‐Jung Kim, (unknown), Hwang‐Phill Kim, Sae‐Won Han, Seock‐Ah Im, Tae‐You Kim, Do‐Youn Oh, Yung‐Jue Bang	97
13	Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer 2012 ·Molecular Cancer Therapeutics ·(unknown), Seock‐Ah Im, Do‐Youn Oh, Paul Elvin, Hwang‐Phill Kim, Young‐Kwang Yoon, Ahrum Min, Sang‐Hyun Song, Sae‐Won Han, Tae‐You Kim, Yung‐Jue Bang	50
14	Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells 2011 ·Cancer Letters ·Young‐Kwang Yoon, Hwang‐Phill Kim, Sang‐Hyun Song, Sae‐Won Han, Do Youn Oh, Seock‐Ah Im, Yung‐Jue Bang, Tae‐You Kim	8
15	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells 2011 ·Anti-Cancer Drugs ·Hye Jin Kim, Hwang‐Phill Kim, Young‐Kwang Yoon, (unknown), (unknown), Sae‐Won Han, Seock‐Ah Im, Tae‐You Kim, Do‐Youn Oh, Yung‐Jue Bang	23
16	Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells 2009 ·Molecular Cancer Therapeutics ·Young‐Kwang Yoon, Hwang‐Phill Kim, Sae‐Won Han, Hyung-Seok Hur, Do Youn Oh, Seock‐Ah Im, Yung‐Jue Bang, Tae‐You Kim	62
17	Enzastaurin, a Protein Kinase Cβ Inhibitor, Suppresses Signaling through the Ribosomal S6 Kinase and Bad Pathways and Induces Apoptosis in Human Gastric Cancer Cells 2008 ·Cancer Research ·Keun‐Wook Lee, Sang Gyun Kim, Hwang‐Phill Kim, Euna Kwon, (unknown), (unknown), Jung‐Hyun Park, Byeong‐Cheol Kang, Seock‐Ah Im, Tae‐You Kim, Woo Ho Kim, Yung‐Jue Bang	61
18	The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines 2008 ·Cancer Letters ·Jin Won Kim, Hwang‐Phill Kim, Seock‐Ah Im, (unknown), (unknown), Young‐Kwang Yoon, Do‐Youn Oh, Jee Hyun Kim, Dong Soon Lee, Tae‐You Kim, Yung‐Jue Bang	106
19	Inhibition of cell cycle progression via p27Kip1 upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua Stokes in AGS gastric cancer cells 2006 ·International Journal of Molecular Medicine ·(unknown), Hwang‐Phill Kim, Chang-Hwa Jung, Myung Hee Hong, (unknown), Hyunsu Bae, Sundong Lee, Seon-Yeong Park, (unknown), Seong‐Gyu Ko	43
20	Saussurea lappa induces G2-growth arrest and apoptosis in AGS gastric cancer cells 2004 ·Cancer Letters ·Seong‐Gyu Ko, Hwang‐Phill Kim, (unknown), Hyunsu Bae, Sung Hoon Kim, (unknown), Sang Eun Lee	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact